Literature DB >> 33669123

Central TSH Dysregulation in a Patient with Familial Non-Autoimmune Autosomal Dominant Hyperthyroidism Due to a Novel Thyroid-Stimulating Hormone Receptor Disease-Causing Variant.

Jasna Suput Omladic1,2, Maja Pajek3, Urh Groselj1,2, Katarina Trebusak Podkrajsek2,4, Magdalena Avbelj Stefanija1,2, Mojca Zerjav Tansek1,2, Primoz Kotnik1,2, Tadej Battelino1,2, Darja Smigoc Schweiger1,2.   

Abstract

Background and Objectives. Familial non-autoimmune autosomal dominant hyperthyroidism (FNAH) is a rare cause of childhood hyperthyroidism. It is caused by the thyroid-stimulating hormone receptor (TSHR) gene variants. So far, only around 40 families with FNAH have been reported. Patients with activating TSHR variants demonstrated the same classical signs and symptoms of hyperthyroidism as seen in patients with Graves' disease. Since 2012, ablative therapy is recommended to avoid relapses of hyperthyroidism and its consequences. Case Presentation. We presented a young adult male patient with a novel heterozygous TSHR disease-causing variant p.Arg418Lys (c.1253G>A) in the exon 10, who presented with a mild but progressive FNAH, with a follow-up since infancy. Discussion. Constantly suppressed TSH, including during the euthyreosis in childhood and hypothyreosis after iodine ablation therapy, suggested central dysregulation of the TSH secretion.

Entities:  

Keywords:  FNAH; TSHR; central hypothyroidism; familial non-autoimmune autosomal dominant hyperthyroidism; radioiodine ablation therapy

Year:  2021        PMID: 33669123      PMCID: PMC7996546          DOI: 10.3390/medicina57030196

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  37 in total

1.  Delayed recovery of thyrotropin responsiveness after radioactive iodine therapy for hyperthyroidism.

Authors:  S G Albert; H M Goodgold; J Chehade; J Kim
Journal:  Am J Med Sci       Date:  2000-06       Impact factor: 2.378

2.  Familial neonatal nonautoimmune hyperthyroidism due to a gain-of-function (D619G) thyrotropin-receptor mutation.

Authors:  Doris Taha; Amita Adhikari; Leigh Anne Flore
Journal:  J Pediatr Endocrinol Metab       Date:  2020-11-12       Impact factor: 1.634

3.  Approach to the patient with resistance to thyroid hormone and pregnancy.

Authors:  Roy E Weiss; Alexandra Dumitrescu; Samuel Refetoff
Journal:  J Clin Endocrinol Metab       Date:  2010-07       Impact factor: 5.958

4.  2012 European thyroid association guidelines for the management of familial and persistent sporadic non-autoimmune hyperthyroidism caused by thyroid-stimulating hormone receptor germline mutations.

Authors:  R Paschke; M Niedziela; B Vaidya; L Persani; B Rapoport; J Leclere
Journal:  Eur Thyroid J       Date:  2012-10-04

Review 5.  Shared sporadic and somatic thyrotropin receptor mutations display more active in vitro activities than familial thyrotropin receptor mutations.

Authors:  Julia Lueblinghoff; Markus Eszlinger; Holger Jaeschke; Sandra Mueller; Rifat Bircan; Hulya Gozu; Seda Sancak; Sema Akalin; Ralf Paschke
Journal:  Thyroid       Date:  2010-12-29       Impact factor: 6.568

Review 6.  Genetics and phenomics of inherited and sporadic non-autoimmune hyperthyroidism.

Authors:  Hulya Iliksu Gozu; Julia Lublinghoff; Rifat Bircan; Ralf Paschke
Journal:  Mol Cell Endocrinol       Date:  2010-02-06       Impact factor: 4.102

7.  Sporadic congenital hyperthyroidism due to a spontaneous germline mutation in the thyrotropin receptor gene.

Authors:  H P Holzapfel; P Wonerow; W von Petrykowski; M Henschen; W A Scherbaum; R Paschke
Journal:  J Clin Endocrinol Metab       Date:  1997-11       Impact factor: 5.958

8.  A family with a novel TSH receptor activating germline mutation (p.Ala485Val).

Authors:  Sema Akcurin; Doga Turkkahraman; Carolyn Tysoe; Sian Ellard; Anne De Leener; Gilbert Vassart; Sabine Costagliola
Journal:  Eur J Pediatr       Date:  2008-01-04       Impact factor: 3.183

9.  A new family with an activating mutation (G431S) in the TSH receptor gene: a phenotype discussion and review of the literature.

Authors:  Cæcilie C Larsen; Lefkothea P Karaviti; Victor Seghers; Roy E Weiss; Samuel Refetoff; Alexandra M Dumitrescu
Journal:  Int J Pediatr Endocrinol       Date:  2014-11-17

10.  An A627V-activating mutation in the thyroid-stimulating hormone receptor gene in familial nonautoimmune hyperthyroidism.

Authors:  Jung Hyun Shin; Go Hun Seo; Seung Hwan Oh; Woo Yeong Chung; Hye Young Kim; Young Mi Kim; Mi Hye Bae; Kyung Hee Park; Min Jung Kwak
Journal:  Ann Pediatr Endocrinol Metab       Date:  2020-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.